Delivery Order SPE2DU25D4116-SPE2DU26FH167
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,974.30 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies under a firm fixed price contract. This non-competitive delivery order, issued on December 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- The Defense Logistics Agency awarded a delivery order valued at $15,967.36 to AmerisourceBergen Drug Corp on December 2, 2025, for pharmaceutical products and medical supplies supporting federal healthcare needs. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026), was competitively awarded with no set-aside designation. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,796.20 to AmerisourceBergen Drug Corp on December 7, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $26,469.29 to AmerisourceBergen Drug Corp on November 11, 2025, for pharmaceutical products and medical supplies to support federal healthcare needs. The contract, issued under firm fixed-price terms with no set-aside designation, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $11,508 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, under a firm fixed-price contract with an ultimate completion date of December 9, 2025. This non-set-aside award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The order will be performed at the contractor's corporate office in...
- The Defense Logistics Agency awarded a delivery order contract valued at $5,452.47 to AmerisourceBergen Drug Corp on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 on November 17, 2025, under a firm fixed-price contract. This non-set-aside delivery order is expected to be completed by November 18, 2025, and represents a child contract under the company's larger pharmaceutical supply agreement with the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $11,374.42 to AmerisourceBergen Drug Corp on December 10, 2025, with an ultimate completion date of December 11, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $738,830.10 to AmerisourceBergen Drug Corp on September 6, 2025, for pharmaceutical and medical supply distribution. This firm fixed-price delivery order, which is not set-aside, leverages AmerisourceBergen's position as a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- SPE2DU25D4116Indefinite Delivery Contract
- SPE2DU25D4116-SPE2DU26FH167Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,387.42 to AmerisourceBergen Drug Corp on December 1, 2025, under a firm fixed-price contract for pharmaceutical products and medical supplies. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and serves as a critical pharmaceutical distributor for federal medical procurement needs. AmerisourceBergen Drug Corp is a major healthcare solutions provider with an extensive portfolio of federal contracts supplying brand-name and generic medications, vaccines, medical devices, and specialized commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's DLA Prime Vendor Global Program contract enables it to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with comprehensive pharmaceutical support worldwide. This delivery order reflects AmerisourceBergen's ongoing role as a key vendor within DLA's medical supply chain, supporting critical medication needs across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 11/30/25 |